<?xml version="1.0" encoding="UTF-8"?>
<ref id="cas13719-bib-0021">
 <label>21</label>
 <mixed-citation publication-type="journal" id="cas13719-cit-0021">
  <string-name>
   <surname>Lenz</surname>
   <given-names>G</given-names>
  </string-name>, 
  <string-name>
   <surname>Dreyling</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Hoster</surname>
   <given-names>E</given-names>
  </string-name>, et al. 
  <article-title>Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long‐term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG)</article-title>. 
  <source xml:lang="en">J Clin Oncol</source>. 
  <year>2005</year>;
  <volume>23</volume>:
  <fpage>1984</fpage>‐
  <lpage>1992</lpage>.
  <pub-id pub-id-type="pmid">15668467</pub-id>
 </mixed-citation>
</ref>
